Stockreport

Humacyte (HUMA) Up on HAV BLA Priority Tag for Vascular Trauma [Yahoo! Finance]

Humacyte, Inc.  (HUMA) 
PDF bioengineered tissue, Human Acellular Vessel (HAV), to treat vascular trauma, under Priority Review. A filing designated as a Priority Review reduces the review period b [Read more]